Matthew Shields Insider Trades & Stock Holdings

EVP, Global Operations · Teva Pharmaceutical Industries Limited · Latest filing Jun 18, 2026

Matthew Shields, EVP, Global Operations at Teva Pharmaceutical Industries Limited has 1 Form 4 trade on file since Jun 18, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($321.55K), net -$321.55K. Latest filing: disposed of 9.99K shares of $TEVA on Jun 18, 2026 at $32.19.

Trades on file

1

Open-market bought

$0

Open-market sold

$321.55K

Net open-market

-$321.55K

Latest filing

Jun 18, 2026

All insider trades by Matthew Shields

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Jun 18, 2026	$TEVA	Sell (Open-market sale)	9.99K	$32.19	$321.55K			+6.8%	-1.5%		EVP, Global Operations		Read

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Matthew Shields traded

• $TEVA

Frequently asked questions

Has Matthew Shields been buying or selling stock?

Matthew Shields has 0 open-market purchases and 1 open-market sale on file, net -$321.55K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Matthew Shields's latest insider trade?

disposed of 9.99K shares of $TEVA on Jun 18, 2026 at $32.19.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.